menu
    • menu

    Company profile for Abalos Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise immune responses and activate all relevant immune cell types against primary tumors and met...
    Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abalos TherapeuticsGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Abalos Therapeutics GmbH Alfredstrasse 81, D-45130 Essen
    Telephone
    Telephone
    +49 201 565 787-00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://abalos-tx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abalos Shows ABX-001 Synergy With Bispecific Engagers
    Abalos Shows ABX-001 Synergy With Bispecific Engagers

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180451/0/en/Abalos-Therapeutics-to-Present-Preclinical-Data-Highlighting-Potent-Synergistic-Effects-of-ABX-001-in-Combination-with-Bispecific-T-cell-Engagers-at-SITC-2025.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Abalos Therapeutics Initiates Phase 1 Study Of ABX-001 For Tumors
    Abalos Therapeutics Initiates Phase 1 Study Of ABX-001 For Tumors

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171778/0/en/Abalos-Therapeutics-Doses-First-Patient-in-Phase-1-Study-Evaluating-ABX-001-for-the-Treatment-of-Solid-Tumors.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Abalos Pharma Validates Abx-001 In Cell Reports Medicine
    Abalos Pharma Validates Abx-001 In Cell Reports Medicine

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3165951/0/en/Abalos-Therapeutics-Publishes-in-Cell-Reports-Medicine-Validating-ABX-001-s-Potential-to-Overcome-Cancer-Immunotherapy-Hurdles.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    Abalos Therapeutics Appoints Gerben Moolhuizen As CEO
    Abalos Therapeutics Appoints Gerben Moolhuizen As CEO

    09 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241009727220/en

    BUSINESSWIRE
    09 Oct 2024
    Share Share
    Abalos Therapeutics Appoints Thomas Bogenrieder as CMO
    Abalos Therapeutics Appoints Thomas Bogenrieder as CMO

    19 Oct 2022

    // MEDICALBUYER

    https://www.medicalbuyer.co.in/abalos-therapeutics-appoints-thomas-bogenrieder-as-cmo/#:~:text=Abalos%20Therapeutics%20announced%20today%20the,through%20the%20clinical%20evaluation%20process.

    MEDICALBUYER
    19 Oct 2022
    Share Share
    Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer
    Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer

    18 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221018005074/en

    BUSINESSWIRE
    18 Oct 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search